The systemic immune inflammation index is a reliable and novel risk factor for metabolic dysfunction-associated fatty liver disease
These findings suggest that SII could serve as a useful, noninvasive marker for diagnosing and monitoring MAFLD, warranting further longitudinal studies to explore its role in disease progression and treatment response.
Authors
- Mehmet Ali Kösekli (ORCID: https://orcid.org/0000-0002-3172-8200)
- Gülali Aktaş (ORCID: https://orcid.org/0000-0001-7306-5233)
Institutions
- Bolu Abant İzzet Baysal University (TR)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1080/03007995.2025.2463952
- Citations
- 31
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 41.98